tiprankstipranks
Chromocell Therapeutics Corp (CHRO)
:CHRO
US Market
CHRO
Chromocell Therapeutics Corp
RESEARCH TOOLSreports

Chromocell Therapeutics Corp (CHRO) Income Statement

Compare
32 Followers

Chromocell Therapeutics Corp Income Statement

Last quarter (Q3 2024), Chromocell Therapeutics Corp's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Chromocell Therapeutics Corp's net income was $-1.69M. See Chromocell Therapeutics Corp’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 199.93K
Gross Profit
$ -2.58M$ -391.73K$ -209.05K$ 61.35K
Operating Expenses
$ 6.86M$ 2.32M$ 839.00K$ 1.55M
Depreciation and Amortization
$ 0.00$ 690.45K$ 839.00K$ 1.35M
EBITDA
$ -6.86M$ -1.63M$ 0.00$ 0.00
Operating Income
$ -6.86M$ -2.32M$ -839.00K$ -1.35M
Other Income/Expenses
$ -518.51K$ -140.43K$ 243.61K$ 693.28K
Pretax Income
$ -7.38M$ -2.46M$ -595.39K$ -660.58K
Net Income
$ -7.38M$ -2.46M$ -595.39K$ -660.58K
Per Share Metrics
$ ―$ ―$ ―$ ―
Basic EPS
$ -1.28$ -0.43$ -0.10$ -0.11
Diluted EPS
$ -1.28$ -0.43$ -0.10$ -0.11
Weighted Average Shares Outstanding
5.77M 5.77M 5.77M 5.77M
Weighted Average Shares Outstanding (Diluted)
5.77M 5.77M 5.77M 5.77M
Currency in USD

Chromocell Therapeutics Corp Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis